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Abstract 
 The article presents data on the issue of non-medical use of tropicamide in the 
Republic of Kazakhstan. The authors analysed the clinical characteristics of the polydrug 
abuse as a result of combined use of opioids and tropicamide by sampling drug addicts 
seeking narcological aid.  Results indicate malignant state of substance addiction associated 
with the underlying opioid addiction.  
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Introduction 
Currently the Republic of Kazakhstan faces a steady growth in chemical addictions as a 
result of increased circulation of traditional drugs and the emergence of new psychoactive 
substances. 
Since November 2013 the government has been actively focusing on the over-the-
counter drug problem, taking a number of measures to restrict the distribution of psychotropic 
medications. Such medications include pharmaceutical forms that contain desomorphine, 
codeine, ephedrine and cyclopentolate. 
 To prepare most of the over-the-counter drugs, a drug addict would have to perform a 
number of interim chemical reactions at home, which requires the use of certain precursors.33 
This fact to some degree deters the expansion of desomorphine, codeine and ephedrine abuse 
in our country. Cyclopentolate (tropicamide), unlike other medications, is a solution for 
ocular administration and therefore can be used by addicts without any preliminary treatment. 
Furthermore, tropicamide is often used in combination with such traditional drugs as the 
opioids (heroin), effectively offsetting negative vegetative effects of the latter.34 
Over the three quarters of the year 2013, retail sales of tropicamide in the Republic of 
Kazakhstan increased 226 per cent in the amount of units sold and 216 per cent in monetary 
terms, compared to the same period of 2012.35 These figures leave us wondering about the 
real growth in the popularity of this medication among drug addicts in our country. 
                                                          
33 Shibanova, N. I. (2006). On some issues of the use of narcotic or potent substances based on the results of 
intoxication evaluations. Narcology, 6, 53-56. 
34 Mokhnatchov, S.O., Rokhlina, M.L., Usmanova, N.N. (2012). Clinical manifestations of tropicamide abuse.  
Narcology, 2, 44-50. 
35 Monitoring of retail sales of eye-drop medications in the Republic of Kazakhstan 
http://viortis.kz/files/35_roznica_ls_1_20 
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At the same time, no official statistical monitoring of the extent of non-medical use of 
tropicamide is being done. Furthermore, there is scarcity of research on this subject matter.36  
The purpose of our research consisted in the analysis of the extent, as well as the study 
of characteristics of non-medical use of the tropicamide medication by drug addicts seeking 
narcological medical aid.  
 
Materials and Methods 
By design, this research can be described as an observational and cross-section study.  
The research subjects were drug addicts with polydrug addiction to opioids and 
tropicamide, who underwent the inpatient course of treatment at the Republican Scientific 
and Practical Centre for Medical and Social Problems of Drug Addiction during the period 
between October 2013 through September 2014.  
The sample was formed retrospectively and continuously. The inclusion criterion was 
the diagnosis of combined (polydrug) addiction to several psychoactive substances pursuant 
to ICD-10 F19.2, with one of the psychoactive substances being tropicamide. The research 
excluded under-age persons, persons with associated mental disorders or decompensated 
somatic pathologies. The selection formed using the criteria above consisted of 118 persons. 
Prevalence of tropicamide addiction among patients receiving care during the study period 
was 23.9%. 
The study utilised patient history data, as well as the objective status and dynamic 
characteristics of the study group's patients' condition, gathered from the medical records 
(inpatient and outpatient card).  The study employed the sociological, clinical psychological 
and statistical research methods. 
 
Results of the research 
Men formed the largest part of the study group: 99 persons (83.9%). Average age of the 
group was 29.1±6.4 years, with youngest age being 18, and the oldest — 41.  Table 1 
presents the age distribution of the group.  All group members were of socially active age.  
Majority of the group members were married (official or civil marriage) — 67 persons 
(56.8%) and had the immediate microsocial environment — 90 persons (76.3%). 38 persons 
(32.2%) were unemployed, with only 23 persons (19.5%) had a regular job. 
Table 1. Social and demographic indicators of the study group 
 
Study group (n=118) 
Absolute Amount Percentage 
Age range 
18–24 31 26.3% 
25–35 64 54.2% 
Over 35 23 19.5% 
Marital status 
single 31 26.3% 
married 44 37.3% 
civil marriage 23 19.5% 
divorced 20 16.9% 
Closest circle 
parents 32 27.1% 
family 46 39% 
relatives 10 8.5% 
friends 2 1.7% 
unaided living 28 23.7% 
                                                          
36 Zabransky, T. ed. (2012). National Report on the Drug Situation in the Republic of Kazakhstan for 2012 
(Drug Situation 2011). Astana/Prague:   Republican Scientific and Practical Centre for Medical and Social 
Problems of Drug Addiction, CADAP, 114. 
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Employment 
regular employment 23 19.5% 
temporary job 52 44.1% 
unemployment 38 32.2% 
education 5 4.2% 
 
Hereditary burden of chemical addictions and psychiatric disorders is presented in 
Diagram 1. It was established that the group presents almost evenly with hereditary burden of 
both chemical addictions and psychiatric disorders (schizophrenia, manic depressive 
psychosis, adaptation disorders). 
 
Diagram 1. Hereditary Burden in Study Group Patients (n=118) 
 
 Average length of tropicamide abuse in the study group amounted to 3.47±2.1 years, 
in the 1–9 year range. 
Along with tropicamide abuse, 17 persons (14.4%) were addicted to natural opium, 92 
persons (78%) — addicted to heroin, and 9 persons (7.6%) —to synthetic opiates (tramadol, 
desomorphine). 
The following reasons were given for the first use of tropicamide: search for new 
sensations — 23 persons (19.5%), submissive motive (peer pressure) — 44 persons (37.3%), 
to compensate for the shortage of opiates — 51 persons (43.2%). 
As factors contributing to systematic tropicamide use after the first tries the following 
were named: general over-the-counter availability — 39 persons (33.1%); cheap price when 
compared to traditional drugs — 51 persons (43.2%); more pleasant experience — 28 persons 
(23.7%). 
In all cases tropicamide addiction was of secondary nature and complicated the primary 
opioid addiction. Length of polydrug abuse of the primary drug and tropicamide averaged at 
22.7±11.3 months. Etiopathogenesis of the polydrug addiction was of the substitution variety 
(to compensate for the lack of the primary drug) in 52 cases (44.1%), corrective variety (for 
attenuation of unwanted side effects of the primary drug) in 47 cases (39.8%) and of true 
variety (a prominent tropicamide addiction competing with the primary drug addiction) in 19 
cases (16.1%). 
All subjects administered both the primary drugs and tropicamide intravenously, on 
average 2-3 times per day. Drug doses were significantly higher than the maximum 
therapeutic doses — on average by 6.4±3.2 ml per day.  Maximum daily dosage reached 
14.9±5.9 ml. 
Clinical course of tropicamide addiction was characterised by quick rate of onset of 
psychopathological symptoms. Psychological dependence in subjects developed within 
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9.1±3.8 weeks; regular use — at 12.1±4.1 weeks, and physical dependence developed within 
14.7±4.4 weeks. Tropicamide abstinence lengths were shorter than those of opioids (7.5±4.7 
and 8.5±6.9 months respectively). 
Clinical complications resulting from tropicamide abuse were registered in 53 cases 
(44.9%): intoxicational psychosis in Hx — 19 subjects (16.1%); post-injection purulent 
complications of the soft tissues in Hx — 7 subjects (5.9%); cardiovascular toxicity — 11 
subjects (20.8%); nervous system involvement — 21 subjects (39.6%). 
 
Discussion of Results 
 The study revealed that the non-medical use of tropicamide is secondary to the opioid 
dependence. This fact correlates with previous research on pathomorphism of opioid 
addiction in the post-Soviet bloc.3738  Tropicamide use among drug addicts in Kazakhstan is 
most commonly caused by the need to substitute the narcotic effect of heroin, inflow of 
which has been limited by the state anti-drug campaigns.  Upsurge of "popularity" of this 
medication can be explained by the insufficiently effective measures toward treatment and 
rehabilitation of opioid dependence and constitutes its complication. 
Clinical characteristics of tropicamide addiction revealed in this study are indicative of 
the malignant course of the addiction (high speed of addiction syndrome development, 
pronounced toxicity and high rate of complications). Also notable is the fact that tropicamide 
dependence is prevalent among persons of active social age with a developed immediate 
social circle, which can further contribute to popularisation of this substance. Analysis of the 
motivation behind trying such medications for the first time speaks to the necessity of 
strengthening measures to restrict the drug-store distribution of a number of medications 
through. 
 
Conclusion 
Study of the issue of non-medical use of medications like tropicamide remains a highly 
relevant topic for the addiction science of the Republic of Kazakhstan. Much needed is 
thorough clinical research which would allow identification of the targets for therapeutic 
interventions and development of medical and social rehabilitation programmes for the 
corresponding group of addicted individuals. 
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